We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Zydus Hit With Cancer Drug Patent Suit Over Xtandi
Zydus Hit With Cancer Drug Patent Suit Over Xtandi
Astellas Pharma and two other plaintiffs have filed a patent infringement lawsuit in an effort to stop Zydus Pharmaceuticals from marketing a generic version of the prostate cancer drug Xtandi (enzalutamide).